The European & Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
EDCTP2 Portfolio I
Overview of the EDCTP2 portfolio of Collaborative Research & Development projects 2014-2019. profiles for each project.
EDCTP2 Portfolio II
Overview of the EDCTP2 Portfolio: Fellowship programme 2014-2019. Profiles for each fellowship.
Professor Gita Ramjee passed away on 31 March 2020
Yesterday, Professor Gita Ramjee, Chief Scientific Officer of the Aurum Institute in South Africa, passed away due to complications of a COVID-19 infection. Many in the EDCTP General Assembly, the Scientific Advisory Committee and the Secretariat worked with her and…
Total EDCTP investment in TB research & development rises to € 228 million
On World TB Day 2020, the COVID-19 pandemic is a stark reminder of the global impact and burden of infectious diseases on individual and public health, society and national economies. Since 1997, the World Health Organisation (WHO) has reported on…